October 16 webinar: How to take your life sciences company public in the U.S.

Register today for the upcoming Canadian Trade Commissioner Service webinar on initial public offerings (IPO) in the U.S. life sciences sector.

Why should you participate? You will learn:

1. Why an IPO might make sense for a life sciences company;
2. How to prepare for an IPO from an Investor Relations/Communications perspective;
3. The IPO process/considerations from a legal perspective;
4. SEC requirements for a dual listing and alternative exchanges;
5. Cost of going public; and
6. Life after going public

A panel of experts will review key issues that should be considered by Canadian life sciences companies before starting the process of going public in the U.S.

Date: Wednesday, October 16, 2013
Time: 1:00 to 2:00 p.m. (Ottawa time)
Cost: Free
Register by Thursday, October 10, 2013

The panel includes: Donna LaVoie, President & CEO, LaVoie Strategic Communications Group; Christine Gallagher, Managing Director, Equity Capital Markets, SunTrust Robinson Humphrey; and Greg Hogan, Partner, Securities Group of Cassels Brock. Leonard M. Gold, Partner, Chair of the Canadian Practice of Burns & Levinson LLP in Boston, will be the moderator.

After the presentation, there will be a 10-minute Q&A period. The presentation will be in English, but the speakers will take questions in both French and English. We invite you to provide your questions in advance to Christine.Wong@international.gc.ca.

For more information, contact Christine Wong at christine.wong@international.gc.ca or call 613-944-6466.